Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

The Human Pathogen Streptococcus pyogenes Releases Lipoproteins as Lipoprotein-rich Membrane Vesicles.

Biagini M, Garibaldi M, Aprea S, Pezzicoli A, Doro F, Becherelli M, Taddei AR, Tani C, Tavarini S, Mora M, Teti G, D'Oro U, Nuti S, Soriani M, Margarit I, Rappuoli R, Grandi G, Norais N.

Mol Cell Proteomics. 2015 Aug;14(8):2138-49. doi: 10.1074/mcp.M114.045880. Epub 2015 May 27.

PMID:
26018414
2.

Protective immunogenicity of group A streptococcal M-related proteins.

Dale JB, Niedermeyer SE, Agbaosi T, Hysmith ND, Penfound TA, Hohn CM, Pullen M, Bright MI, Murrell DS, Shenep LE, Courtney HS.

Clin Vaccine Immunol. 2015 Mar;22(3):344-50. doi: 10.1128/CVI.00795-14. Epub 2015 Jan 28.

3.

A naturally occurring single amino acid replacement in multiple gene regulator of group A Streptococcus significantly increases virulence.

Sanson M, O'Neill BE, Kachroo P, Anderson JR, Flores AR, Valson C, Cantu CC, Makthal N, Karmonik C, Fittipaldi N, Kumaraswami M, Musser JM, Olsen RJ.

Am J Pathol. 2015 Feb;185(2):462-71. doi: 10.1016/j.ajpath.2014.10.018. Epub 2014 Dec 2.

4.

In vivo expression of Streptococcus pyogenes immunogenic proteins during tibial foreign body infection.

Freiberg JA, McIver KS, Shirtliff ME.

Infect Immun. 2014 Sep;82(9):3891-9. doi: 10.1128/IAI.01831-14. Epub 2014 Jul 7.

5.

The effects of methionine acquisition and synthesis on Streptococcus pneumoniae growth and virulence.

Basavanna S, Chimalapati S, Maqbool A, Rubbo B, Yuste J, Wilson RJ, Hosie A, Ogunniyi AD, Paton JC, Thomas G, Brown JS.

PLoS One. 2013;8(1):e49638. doi: 10.1371/journal.pone.0049638. Epub 2013 Jan 22.

6.

Surface interactome in Streptococcus pyogenes.

Galeotti CL, Bove E, Pezzicoli A, Nogarotto R, Norais N, Pileri S, Lelli B, Falugi F, Balloni S, Tedde V, Chiarot E, Bombaci M, Soriani M, Bracci L, Grandi G, Grifantini R.

Mol Cell Proteomics. 2012 Apr;11(4):M111.015206. doi: 10.1074/mcp.M111.015206. Epub 2011 Dec 22.

7.

Benfang Lei's research on heme acquisition in Gram-positive pathogens and bacterial pathogenesis.

Lei B.

World J Biol Chem. 2010 Sep 26;1(9):286-90. doi: 10.4331/wjbc.v1.i9.286.

8.

The Streptococcus pyogenes proteome: maps, virulence factors and vaccine candidates.

Dmitriev AV, Chaussee MS.

Future Microbiol. 2010 Oct;5(10):1539-51. doi: 10.2217/fmb.10.116. Review.

9.

Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.

Bronze MS, Dale JB.

Am J Med Sci. 2010 Sep;340(3):218-25. doi: 10.1097/MAJ.0b013e3181e939ab. Review.

10.

Pooled protein immunization for identification of cell surface antigens in Streptococcus sanguinis.

Ge X, Kitten T, Munro CL, Conrad DH, Xu P.

PLoS One. 2010 Jul 26;5(7):e11666. doi: 10.1371/journal.pone.0011666.

11.

Novel conserved group A streptococcal proteins identified by the antigenome technology as vaccine candidates for a non-M protein-based vaccine.

Fritzer A, Senn BM, Minh DB, Hanner M, Gelbmann D, Noiges B, Henics T, Schulze K, Guzman CA, Goodacre J, von Gabain A, Nagy E, Meinke AL.

Infect Immun. 2010 Sep;78(9):4051-67. doi: 10.1128/IAI.00295-10. Epub 2010 Jul 12.

12.

A decade of molecular pathogenomic analysis of group A Streptococcus.

Musser JM, Shelburne SA 3rd.

J Clin Invest. 2009 Sep;119(9):2455-63. doi: 10.1172/JCI38095. Review.

13.

Screening of Streptococcus pneumoniae ABC transporter mutants demonstrates that LivJHMGF, a branched-chain amino acid ABC transporter, is necessary for disease pathogenesis.

Basavanna S, Khandavilli S, Yuste J, Cohen JM, Hosie AH, Webb AJ, Thomas GH, Brown JS.

Infect Immun. 2009 Aug;77(8):3412-23. doi: 10.1128/IAI.01543-08. Epub 2009 May 26.

14.

Contribution of lipoproteins and lipoprotein processing to endocarditis virulence in Streptococcus sanguinis.

Das S, Kanamoto T, Ge X, Xu P, Unoki T, Munro CL, Kitten T.

J Bacteriol. 2009 Jul;191(13):4166-79. doi: 10.1128/JB.01739-08. Epub 2009 Apr 24.

15.

The Two-Component Regulatory System VicRK is Important to Virulence of Streptococcus equi Subspecies equi.

Liu M, McClure MJ, Zhu H, Xie G, Lei B.

Open Microbiol J. 2008;2:89-93. doi: 10.2174/1874285800802010089. Epub 2008 Jun 19.

16.

Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis.

Shelburne SA 3rd, Keith DB, Davenport MT, Horstmann N, Brennan RG, Musser JM.

Mol Microbiol. 2008 Jul;69(2):436-52. doi: 10.1111/j.1365-2958.2008.06290.x.

17.
18.
19.

MalE of group A Streptococcus participates in the rapid transport of maltotriose and longer maltodextrins.

Shelburne SA 3rd, Fang H, Okorafor N, Sumby P, Sitkiewicz I, Keith D, Patel P, Austin C, Graviss EA, Musser JM, Chow DC.

J Bacteriol. 2007 Apr;189(7):2610-7. Epub 2007 Jan 26.

20.

Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation.

Hamilton A, Robinson C, Sutcliffe IC, Slater J, Maskell DJ, Davis-Poynter N, Smith K, Waller A, Harrington DJ.

Infect Immun. 2006 Dec;74(12):6907-19. Epub 2006 Oct 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk